Top 5 - yesterday

Top 5 - last week

Top 5 - last month

Stakeholders blaming FDA ‘inaction’ on CBD

US: Major decline for hemp industry in 2022, USDA report shows

The hemp industry took a major plunge in 2022, a new report from the U.S. Department of Agriculture (USDA) shows, and stakeholders say the Food and Drug Administration’s (FDA) refusal to issue regulations for CBD products is largely to blame.

USDA’s National Hemp Report shows significant losses in the value and cultivation of the non-intoxicating cannabis crop across every metric that it analyzed for 2022.

Last year, “the value of hemp production in the open and under protection for the United States totaled $238 million, down 71 percent from 2021,” the report says.

Farmers grew 28,314 acres of industrial hemp in the open last year, which is nearly 50 percent lower than the prior year. Floral hemp production fell 66 percent, grain hemp dropped 44 percent, fiber hemp declined by 34 percent, seed hemp plummeted 92 percent, and hemp clones/transplants were down 94 percent.


Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.